Label: HYALURONIC ACID SODIUM SALT 0.5% / HYDROQUINONE 4% / TRETINOIN 0.05% emulsion

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated May 17, 2019

If you are a consumer or patient please visit this version.

  • Directions for use

    ws

  • Sincerus Florida, LLC. Adverse reactions

    xz

  • Active, inactive

    ad

  • NDC 72934- 6089-2 HYALURONIC ACID SODIUM SALT 0.5% / HYDROQUINONE USP 4% / TRETINOIN USP 0.05%. Emulsion 30 gm.

    ad

  • INGREDIENTS AND APPEARANCE
    HYALURONIC ACID SODIUM SALT 0.5% / HYDROQUINONE 4% / TRETINOIN 0.05% 
    hyaluronic acid sodium salt 0.5% / hydroquinone 4% / tretinoin 0.05% emulsion
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-6089
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM0.5 g  in 100 g
    TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R) TRETINOIN0.05 g  in 100 g
    HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE4 g  in 100 g
    Product Characteristics
    ColoryellowScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72934-6089-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/17/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/17/2019
    Labeler - Sincerus Florida, LLC (080105003)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sincerus Florida, LLC080105003manufacture(72934-6089)